Showing results (1921-1930 of 2,565) with videos related to

Sort By:
Pageof 257
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1989
[Q fever infectious endocarditis. Apropos of a new case]C Soubrane, M Bellorini, J Granier, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1992
Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditisG Potel, J Caillon, F Le Gallou, et al.
Human Immunology|November 24, 1999
Acquisition of a stimulatory activity for Vgamma9/Vdelta2 T cells by a Burkitt's lymphoma cell line without loss of HLA class I expressionF E L'Faqihi, M Guiraud, N Dastugue, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2000
Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3AM Gantenbein, L Attolini, B Bruguerolle, et al.
Circulation|June 28, 2000
Mapping and ablation of left atrial fluttersP Jaïs, D C Shah, M Haïssaguerre, et al.
Infection Control and Hospital Epidemiology|December 4, 2018
The clinical impact of a urinary tract infection management bundle in a tertiary-care teaching hospitalTimothy D MacLaggan, Christopher P Le, Kristen A Iverson, et al.
American Journal of Nephrology|January 1, 1988
Effects of ciclosporin on plasma renin activity, catecholamines and prostaglandins in patients with idiopathic uveitisG Deray, P Le Hoang, P Cacoub, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 12, 2001
Immunologic events and long-term survival after combined heart and kidney transplantation: a 12-year single-center experienceE Vermès, M Kirsch, R Houël, et al.
Autoimmunity|January 1, 1995
The relationship of anti-endothelial cell antibodies to anti-phospholipid antibodies in patients with giant cell arteritis and/or polymyalgia rheumaticaM Le Tonquèze, M Dueymes, Y Giovangrandi, et al.
British Journal of Cancer|July 17, 2003
Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell linesC M M van Geelen, E G E de Vries, T K P Le, et al.
Pageof 257